Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Laboratory of Biochemistry, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
J Lipid Res. 2022 Jul;63(7):100235. doi: 10.1016/j.jlr.2022.100235. Epub 2022 May 30.
Ceramides are essential lipids for skin permeability barrier function, and a wide variety of ceramide species exist in the stratum corneum (SC). Although ceramides with long-chain bases (LCBs) of various lengths have been identified in the human SC, a quantitative analysis that distinguishes ceramide species with different LCB chain lengths has not been yet published. Therefore, the whole picture of human SC ceramides remains unclear. Here, we conducted LC/MS/MS analyses to detect individual ceramide species differing in both the LCB and FA chain lengths and quantified 1,327 unbound ceramides and 254 protein-bound ceramides: the largest number of ceramide species reported to date. Ceramides containing an LCB whose chain length was C16-26 were present in the human SC. Of these, C18 (28.6%) was the most abundant, followed by C20 (24.8%) and C22 (12.8%). Each ceramide class had a characteristic distribution of LCB chain lengths and was divided into five groups according to this distribution. There was almost no difference in FA composition between the ceramide species containing LCBs of different chain lengths. Furthermore, we demonstrated that one of the serine palmitoyltransferase (SPT) complexes, SPTLC1/SPTLC3/SPTSSB, was able to produce C16-24 LCBs. The expression levels of all subunits constituting the SPT complexes increased during keratinocyte differentiation, resulting in the observed chain-length diversity of LCBs in the human SC. This study provides a molecular basis for elucidating human SC ceramide diversity and the pathogenesis of skin disorders.
神经酰胺是皮肤渗透性屏障功能所必需的脂质,在角质层(SC)中存在多种神经酰胺种类。尽管已经在人类 SC 中鉴定出具有各种长度长链碱基(LCB)的神经酰胺,但尚未发表区分具有不同 LCB 链长的神经酰胺种类的定量分析。因此,人类 SC 神经酰胺的全貌尚不清楚。在这里,我们进行了 LC/MS/MS 分析,以检测 LCB 和 FA 链长均不同的单个神经酰胺种类,并定量了 1,327 种未结合的神经酰胺和 254 种蛋白结合的神经酰胺:这是迄今为止报道的最多的神经酰胺种类。人类 SC 中存在含有 LCB 链长为 C16-26 的神经酰胺。在这些神经酰胺中,C18(28.6%)最为丰富,其次是 C20(24.8%)和 C22(12.8%)。每种神经酰胺类都具有特征性的 LCB 链长分布,并根据该分布分为五组。不同链长 LCB 所含神经酰胺的 FA 组成几乎没有差异。此外,我们证明了一个丝氨酸棕榈酰转移酶(SPT)复合物,SPTLC1/SPTLC3/SPTSSB,能够产生 C16-24 LCB。构成 SPT 复合物的所有亚基的表达水平在角质形成细胞分化过程中增加,导致人类 SC 中 LCB 的观察到的链长多样性。这项研究为阐明人类 SC 神经酰胺多样性和皮肤疾病的发病机制提供了分子基础。